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1726-4Risk factors of meningiomaMeningioma is a common pathology in the central nervous
system (CNS). It arises from the arachnoid cap cells of the
arachnoid villi in the meninges, which envelop the brain and
spinal cord. Therefore, a meningioma can occur anywhere
from the vertex to the spine. It is often named according to its
anatomical location. For example, a meningioma abutting the
sphenoid bone between the frontal and temporal lobes is called
a sphenoid ridge meningioma. A meningioma can be malig-
nant, but it is usually benign and causes few symptoms until it
reaches a large size. Because of the slow rate of tumor growth,
a meningioma that is found incidentally may require no
treatment other than periodic follow up. For symptomatic
meningioma, an intradural extra-axial neoplasm can be man-
aged with surgical resection when it produces a significant
mass effect or can be managed with radiosurgery if its max-
imal diameter is <3 cm. With the advances in modern image
technology (e.g., magnetic resonance images), contemporary
neurosurgical practice usually obtains good results in the
treatment of a meningioma.
The risk factors of meningioma remain elusive. Epidemi-
ology studies have demonstrated a higher prevalence rate of
meningioma in women.1 Type 2 neurofibromatosis (NF) is
frequently associated with multiple meningiomas, whereas
type 1 NF is not associated with an increased risk of menin-
gioma.2 The most common genetic mutations involved in
meningiomas are inactivation of the NF 2 gene on chromosome
22q. There are several other genes that may be involved in the
development of meningioma such as the AKT1, MN1, and
PTEN genes.3,4 Environmental causes, ionizing radiation, and
exogenous hormones have also been correlated with intra-
cranial meningioma in several previous studies.5e8 Despite
these reports, the actual etiology and risk factors of meningi-
oma in the CNS remain uncertain.
In this issue of the Journal of the Chinese Medical Associ-
ation, there is an interesting article entitled “Risk of meningi-
oma in patients with head injury: A nationwide population-
based study”, by Dr. Kuan and colleagues.9 The authors
should be commended for utilizing a large data analysis to
investigate the association between head injury and meningi-
oma.9 They compared 75,292 patients with head injury to a
matched cohort without head injury (as the control). During the
follow-up of approximately 430,000 person-years, they found
17 meningioma cases in the head injury cohort and 14 men-
ingioma cases in the control cohort. Therefore, the authors
concluded that head injury is an unlikely cause of meningioma.x.doi.org/10.1016/j.jcma.2014.07.005
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical AssHowever, there are several caveats to the study. The follow-up
period in this cohort was relatively short and variable (e.g., an
average of 5 years and ranging from 31 days to 10 years). Con-
sidering the fact that a meningioma is a slow-growing tumor, a
longer follow-up is required to establish a correlation between it
and various etiologies. The incidence rates of meningioma were
as low as 3.23 per 100,000 person-years reported in the current
study. With such low incidence rates, a case-controlled study
designwould bemore appropriate to elucidate the causal effect of
head injury. Furthermore, the heterogeneity of the head injury
cohort is a significant concern. It is reasonable to infer that con-
cussion, contusional brain hemorrhage, and diffuse axonal injury
cause a great variety of effects in oncogenesis. These con-
founding factors would limit the power of this study. Further
investigation is encouraged to explore the causes of meningioma
and other oncology in the CNS.Conflicts of interest
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